Search Results

There's a Canadian company doing a phase III study that they say in earlier trials showed a 55% relative risk reduction for MACE in cardiovascular disease patients and a 77% reduction for those with diabetes mellitus. Its epigentics which is a relatively new field in the biotech world....any...

Hi all, Joe...Canadian, 50 years of age but not Diabetic, however it runs in my family so it is a concern. My late father had it as did my great grandmother....my Dad seemed to think it perhaps skipped a generation with us, and I have 3 kids so I'm hoping they don't develop it. Both my Great...